Mission:

To fund research with the highest probability of preventing, slowing, or reversing Alzheimer's disease through venture-based philanthropy.

• Since its founding, Cure Alzheimer's Fund has contributed more than $27,400,000 to research, and its funded initiatives have been responsible for several key breakthroughs - including a potential treatment recently selected by the National Institutes of Health (NIH) for its elite "Blueprint" drug discovery program, and the ground-breaking "Alzheimer's in a Dish" study, which promises to greatly accelerate drug testing and was reported by the New York Times as a "giant step forward".
• Cure Alzheimer's Fund supports some of the best scientific minds in the field of Alzheimer's research, and it does so without any financial gain for its founders or donors.
• Fully 100 percent of funds raised by Cure Alzheimer's Fund go directly to research - the Board of Directors covers all overhead expenses.
• Our Research Consortium is an all-star team of scientists working at premier research institutions across the country, regularly conferring with one another on the progress and impediments in their research and constantly sharing their data.
• Our goal is to stop Alzheimer's disease through early prediction, prevention and effective intervention in those patients who have become symptomatic.